Strata Skin Sciences Stock Buy Hold or Sell Recommendation
| SSKN Stock | USD 2.68 0.02 0.75% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding STRATA Skin Sciences is 'Strong Sell'. The recommendation algorithm takes into account all of STRATA Skin's available fundamental, technical, and predictive indicators you will find on this site.
Check out STRATA Skin Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as STRATA and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
STRATA |
Execute STRATA Skin Buy or Sell Advice
The STRATA recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on STRATA Skin Sciences. Macroaxis does not own or have any residual interests in STRATA Skin Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute STRATA Skin's advice using the current market data and latest reported fundamentals.
Time Horizon
3 Months |
Risk Tolerance
I am an educated risk taker |
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
STRATA Skin Trading Alerts and Improvement Suggestions
| STRATA Skin Sciences generated a negative expected return over the last 90 days | |
| STRATA Skin Sciences has high historical volatility and very poor performance | |
| STRATA Skin Sciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 33.36 M. Net Loss for the year was (10.83 M) with profit before overhead, payroll, taxes, and interest of 18.12 M. | |
| STRATA Skin Sciences currently holds about 10.04 M in cash with (519 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| STRATA Skin Sciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 64.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: STRATA Skin Sciences Highlights New Clinical Study from Japan Demonstrating Superiority of ... |
STRATA Skin Returns Distribution Density
The distribution of STRATA Skin's historical returns is an attempt to chart the uncertainty of STRATA Skin's future price movements. The chart of the probability distribution of STRATA Skin daily returns describes the distribution of returns around its average expected value. We use STRATA Skin Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of STRATA Skin returns is essential to provide solid investment advice for STRATA Skin.
| Mean Return | -0.12 |
| Value At Risk | -5.4 |
| Potential Upside | 5.15 |
| Standard Deviation | 3.19 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of STRATA Skin historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
STRATA Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as STRATA Skin, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading STRATA Skin Sciences back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | |||
| Carmichael Hill & Associates Inc | 2024-09-30 | 300 | |
| Jpmorgan Chase & Co | 2024-12-31 | 106 | |
| Financial Perspectives Inc | 2024-12-31 | 101 | |
| Bank Of America Corp | 2024-12-31 | 20.0 | |
| Hanson Mcclain Inc | 2024-12-31 | 5.0 | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1.0 | |
| Acadian Asset Management Llc | 2024-12-31 | 0.0 | |
| Northern Trust Investments N A | 2024-12-31 | 0.0 | |
| Fmr Inc | 2024-09-30 | 0.0 | |
| 22nw, Lp | 2024-12-31 | 537 K | |
| Nantahala Capital Management, Llc | 2024-12-31 | 403.9 K |
STRATA Skin Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 2.5M | (5.5M) | (5.8M) | 1.3M | 1.2M | 814.7K | |
| Free Cash Flow | (63K) | (2.1M) | (4.7M) | (5.5M) | (6.4M) | (6.7M) | |
| Depreciation | 3.9M | 4.1M | 5.7M | 5.9M | 6.8M | 7.1M | |
| Other Non Cash Items | 114K | (1.9M) | 316K | 3.3M | 3.8M | 2.2M | |
| Capital Expenditures | 2.2M | 3.7M | 3.6M | 5.0M | 5.8M | 6.1M | |
| Net Income | (4.4M) | (2.7M) | (5.5M) | (10.8M) | (12.5M) | (13.1M) | |
| End Period Cash Flow | 18.1M | 12.6M | 6.8M | 8.1M | 7.3M | 10.5M | |
| Change To Inventory | (417K) | (45K) | (1.5M) | 689K | 620.1K | 651.1K | |
| Change To Netincome | 978K | 1.1M | 2.0M | (233K) | (209.7K) | (199.2K) | |
| Net Borrowings | (3.4M) | (296K) | 2.5M | 225K | 202.5K | 192.4K | |
| Investments | (2.2M) | (7.1M) | (4.2M) | (4.7M) | (4.2M) | (4.4M) |
STRATA Skin Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to STRATA Skin or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that STRATA Skin's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a STRATA stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.11 | |
β | Beta against Dow Jones | 0.34 | |
σ | Overall volatility | 3.26 | |
Ir | Information ratio | -0.02 |
STRATA Skin Volatility Alert
STRATA Skin Sciences exhibits very low volatility with skewness of 0.76 and kurtosis of 2.1. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure STRATA Skin's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact STRATA Skin's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.STRATA Skin Fundamentals Vs Peers
Comparing STRATA Skin's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze STRATA Skin's direct or indirect competition across all of the common fundamentals between STRATA Skin and the related equities. This way, we can detect undervalued stocks with similar characteristics as STRATA Skin or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of STRATA Skin's fundamental indicators could also be used in its relative valuation, which is a method of valuing STRATA Skin by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare STRATA Skin to competition |
| Fundamentals | STRATA Skin | Peer Average |
| Return On Equity | -0.73 | -0.31 |
| Return On Asset | -0.0885 | -0.14 |
| Profit Margin | (0.29) % | (1.27) % |
| Operating Margin | (0.19) % | (5.51) % |
| Current Valuation | 20.22 M | 16.62 B |
| Shares Outstanding | 4.17 M | 571.82 M |
| Shares Owned By Insiders | 2.91 % | 10.09 % |
| Shares Owned By Institutions | 63.80 % | 39.21 % |
| Number Of Shares Shorted | 590 | 4.71 M |
| Price To Earning | (0.49) X | 28.72 X |
| Price To Book | 1.16 X | 9.51 X |
| Price To Sales | 0.34 X | 11.42 X |
| Revenue | 33.36 M | 9.43 B |
| Gross Profit | 18.12 M | 27.38 B |
| EBITDA | (3.38 M) | 3.9 B |
| Net Income | (10.83 M) | 570.98 M |
| Cash And Equivalents | 10.04 M | 2.7 B |
| Cash Per Share | 0.29 X | 5.01 X |
| Total Debt | 15.63 M | 5.32 B |
| Debt To Equity | 0.35 % | 48.70 % |
| Current Ratio | 1.30 X | 2.16 X |
| Book Value Per Share | 2.24 X | 1.93 K |
| Cash Flow From Operations | (519 K) | 971.22 M |
| Short Ratio | 0.47 X | 4.00 X |
| Earnings Per Share | (2.60) X | 3.12 X |
| Price To Earnings To Growth | (0.02) X | 4.89 X |
| Target Price | 11.0 | |
| Number Of Employees | 99 | 18.84 K |
| Beta | 1.33 | -0.15 |
| Market Capitalization | 11.18 M | 19.03 B |
| Total Asset | 42.02 M | 29.47 B |
| Retained Earnings | (238.06 M) | 9.33 B |
| Working Capital | 3.37 M | 1.48 B |
Note: Acquisition by Humphries William D. of 14783 shares of STRATA Skin at 1.582 subject to Rule 16b-3 [view details]
STRATA Skin Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as STRATA . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About STRATA Skin Buy or Sell Advice
When is the right time to buy or sell STRATA Skin Sciences? Buying financial instruments such as STRATA Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having STRATA Skin in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Government Funds Thematic Idea Now
Government Funds
Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out STRATA Skin Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets | Return On Equity |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.